Current status of polymeric gene delivery systems.
暂无分享,去创建一个
[1] T. Park,et al. A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[2] D. Davidson,et al. Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs , 2000, Gene Therapy.
[3] Kyung Chul Cho,et al. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[4] F. Liu,et al. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA. , 1999, Human gene therapy.
[5] T. Park,et al. Biodegradable polymeric microcellular foams by modified thermally induced phase separation method. , 1999, Biomaterials.
[6] V. Alakhov,et al. Enhancement of the polycation‐mediated DNA uptake and cell transfection with Pluronic P85 block copolymer , 1996, FEBS letters.
[7] T. Chandy,et al. Chitosan--as a biomaterial. , 1990, Biomaterials, artificial cells, and artificial organs.
[8] Mark E. Davis,et al. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. , 2004, European journal of cell biology.
[9] Michael Simons,et al. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo , 1992, Nature.
[10] L G Griffith,et al. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes , 2005, Gene Therapy.
[11] S. W. Kim,et al. Biodegradable Polyester, Poly[α-(4-Aminobutyl)-l-Glycolic Acid], as a Non-Toxic Gene Carrier , 2004, Pharmaceutical Research.
[12] C. Ahn,et al. Biodegradable poly(ethylenimine) for plasmid DNA delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[13] Minhyung Lee,et al. Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction. VEGF gene therapy for myocardial infarction. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[14] T. Park,et al. Biodegradable Triblock Copolymer of PLGA-PEG-PLGA Enhances Gene Transfection Efficiency , 2004, Pharmaceutical Research.
[15] M. Bednarski,et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.
[16] S. W. Kim,et al. Development of biomaterials for gene therapy. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[17] E Ruoslahti,et al. RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.
[18] T. Park,et al. Controlled release of plasmid DNA from biodegradable scaffolds fabricated using a thermally-induced phase-separation method , 2004, Journal of biomaterials science. Polymer edition.
[19] A. Maruyama,et al. Terplex DNA Delivery System As a Gene Carrier , 2004, Pharmaceutical Research.
[20] M. Hashida,et al. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. , 1998, The Journal of pharmacology and experimental therapeutics.
[21] Wenjin Guo,et al. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. , 2001, Bioconjugate chemistry.
[22] D. Carlo,et al. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. , 1999, Biochimica et biophysica acta.
[23] D. Fischer,et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[24] T. Tuschl,et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.
[25] S. W. Kim,et al. Development of a safe gene delivery system using biodegradable polymer, poly[α-(4-aminobutyl)-L-glycolic acid] [19] , 2000 .
[26] S. W. Kim,et al. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. , 1998, Bioconjugate chemistry.
[27] S. W. Kim,et al. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[28] A. Mikos,et al. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. , 1999, Journal of biomedical materials research.
[29] T. Meade,et al. Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. , 1995, Bioconjugate chemistry.
[30] Steven Edward Kern,et al. Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[31] U. K. Laemmli,et al. Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Coutelle,et al. An araC-controlled Bacterialcre Expression System to Produce DNA Minicircle Vectors for Nuclear and Mitochondrial Gene Therapy* , 2001, The Journal of Biological Chemistry.
[33] K. Kataoka,et al. pH-responsive oligodeoxynucleotide (ODN)-poly(ethylene glycol) conjugate through acid-labile beta-thiopropionate linkage: preparation and polyion complex micelle formation. , 2003, Biomacromolecules.
[34] Khursheed Anwer,et al. Polyvinyl Derivatives as Novel Interactive Polymers for Controlled Gene Delivery to Muscle , 1996, Pharmaceutical Research.
[35] R. Mumper,et al. Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[36] R. Mumper,et al. Plasmid delivery to muscle: Recent advances in polymer delivery systems. , 1998, Advanced drug delivery reviews.
[37] S. W. Kim,et al. Folate-PEG-Folate-Graft-Polyethylenimine-Based Gene Delivery , 2001, Journal of drug targeting.
[38] F. Liu,et al. Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[39] K. Ko,et al. Repression of GAD autoantigen expression in pancreas beta-Cells by delivery of antisense plasmid/PEG-g-PLL complex. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[40] Tae Gwan Park,et al. PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[41] T. Park,et al. Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides. , 2001, Bioconjugate chemistry.
[42] Y. Shinohara,et al. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. , 2001, Advanced drug delivery reviews.
[43] D. Bull,et al. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer , 2003, Gene Therapy.
[44] T. Park,et al. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. , 2003, Biomaterials.
[45] J. Kopeček,et al. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. , 2003, Bioconjugate chemistry.
[46] W. Hennink,et al. 2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[47] R. Langer,et al. Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. , 2001, Journal of the American Chemical Society.
[48] Jeffrey Bonadio,et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.
[49] S. Groshen,et al. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. , 2000, Cancer research.
[50] S. Carotta,et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.
[51] R. Havel. Receptor and non-receptor mediated uptake of chylomicron remnants by the liver. , 1998, Atherosclerosis.
[52] R. Lees,et al. Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[53] K. Kataoka,et al. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. , 1997, Bioconjugate chemistry.
[54] Sung Wan Kim,et al. Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.
[55] K. Leong,et al. Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord , 2003, Gene Therapy.
[56] Robert Langer,et al. Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .
[57] N. Bellocq,et al. Effects of structure of beta-cyclodextrin-containing polymers on gene delivery. , 2001, Bioconjugate chemistry.
[58] Ge Liu,et al. Biological Properties of Poly-l-lysine-DNA Complexes Generated by Cooperative Binding of the Polycation* 210 , 2001, The Journal of Biological Chemistry.
[59] K. Kataoka,et al. Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine): a potential carrier for systemic delivery of antisense DNA. , 2001, Biomacromolecules.
[60] T. Park,et al. Polyelectrolyte complex micelles composed of c-raf antisense oligodeoxynucleotide-poly(ethylene glycol) conjugate and poly(ethylenimine): effect of systemic administration on tumor growth. , 2005, Bioconjugate chemistry.
[61] E. Brambilla,et al. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. , 1999, Human gene therapy.
[62] D. Bull,et al. Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system , 2001, Gene Therapy.
[63] P. Artursson,et al. Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo , 2001, Gene Therapy.
[64] N. Ueno,et al. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[65] T. Park,et al. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. , 1999, Journal of biomedical materials research.
[66] T. Park,et al. Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. , 2003, Bioconjugate chemistry.
[67] S. W. Kim,et al. Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery , 2004, Pharmaceutical Research.
[68] J. Chung,et al. Anti-JL1 antibody-conjugated poly (L-lysine) for targeted gene delivery to leukemia T cells. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[69] S. W. Kim,et al. Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[70] R. Cartier,et al. Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems , 2002, Gene Therapy.
[71] T. Kita,et al. An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.
[72] Sung Wan Kim,et al. Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[73] T. Bettinger,et al. Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability , 1998, Pharmaceutical Research.
[74] T. He,et al. Adenoviral vector-mediated gene transfer for human gene therapy. , 2001, Current gene therapy.
[75] A. Klibanov,et al. Protein stability in controlled-release systems , 2000, Nature Biotechnology.
[76] Kazunori Kataoka,et al. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. , 2005, Journal of the American Chemical Society.
[77] D. Scherman,et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[78] M. Ogris,et al. PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.
[79] S. W. Kim,et al. Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[80] Per Artursson,et al. Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells , 1996, Pharmaceutical Research.
[81] Haeshin Lee,et al. DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline). , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[82] M. Garnett,et al. Gene-delivery systems using cationic polymers. , 1999, Critical reviews in therapeutic drug carrier systems.
[83] W. Zimmer,et al. Cell-specific nuclear import of plasmid DNA , 1999, Gene Therapy.
[84] David J. Mooney,et al. DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.
[85] A. Maheshwari,et al. Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity , 2002, Gene Therapy.
[86] S. Ferrari,et al. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo , 1997, Gene Therapy.
[87] S. W. Kim,et al. An angiogenic, endothelial-cell-targeted polymeric gene carrier. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[88] Kinam Park,et al. Polycation gene delivery systems: escape from endosomes to cytosol , 2003, The Journal of pharmacy and pharmacology.
[89] K. Ulbrich,et al. Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. , 1996, Human gene therapy.
[90] H Lennernäs,et al. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[91] J. Nah,et al. Artery wall binding peptide-poly(ethylene glycol)-grafted-poly(L-lysine)-based gene delivery to artery wall cells. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[92] D. Regensburger,et al. Gene transfer into rat heart-derived endothelial cells. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[93] D. Bull,et al. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium , 2003, Gene Therapy.
[94] S. W. Kim,et al. Systemic Administration of TerplexDNA System: Pharmacokinetics and Gene Expression , 2001, Pharmaceutical Research.
[95] Mark E. Davis,et al. New class of polymers for the delivery of macromolecular therapeutics. , 1999 .
[96] R. Mahato,et al. Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[97] Mark E. Davis,et al. Cyclodextrin-modified polyethylenimine polymers for gene delivery. , 2004, Bioconjugate chemistry.
[98] K. Kataoka,et al. Polyion complex micelles as vectors in gene therapy – pharmacokinetics and in vivo gene transfer , 2002, Gene Therapy.
[99] Clive J Roberts,et al. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. , 2002, Bioconjugate chemistry.
[100] R Langer,et al. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. , 1996, Biomaterials.
[101] V. Torchilin,et al. Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. , 1992, Bioconjugate chemistry.
[102] M. Hashida,et al. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[103] Seng H. Cheng,et al. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[104] W. Hennink,et al. Association and Dissociation Characteristics of Polymer/DNA Complexes Used for Gene Delivery , 1999, Pharmaceutical Research.
[105] A. Akgerman,et al. Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO(2). , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[106] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[107] Philip S Low,et al. Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.
[108] Fred D. Ledley,et al. Pharmaceutical Approach to Somatic Gene Therapy , 1996, Pharmaceutical Research.
[109] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[110] K. Kataoka,et al. Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[111] Suna Choi,et al. Control of Blood Glucose by Novel GLP-1 Delivery Using Biodegradable Triblock Copolymer of PLGA-PEG-PLGA in Type 2 Diabetic Rats , 2004, Pharmaceutical Research.
[112] A. Maruyama,et al. A new non-viral DNA delivery vector: the terplex system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[113] S. W. Kim,et al. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice , 2000, Gene Therapy.
[114] I. Kwon,et al. Preparation of chitosan self-aggregates as a gene delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[115] Sung Wan Kim,et al. Water-Soluble and Low Molecular Weight Chitosan-Based Plasmid DNA Delivery , 2001, Pharmaceutical Research.
[116] H. Lipps,et al. Towards safe, non-viral therapeutic gene expression in humans , 2005, Nature Reviews Genetics.
[117] Steven Edward Kern,et al. Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[118] D A Lauffenburger,et al. Optimization of Cell Surface Binding Enhances Efficiency and Specificity of Molecular Conjugate Gene Delivery* , 1998, The Journal of Biological Chemistry.
[119] T. Park,et al. Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. , 2005, Macromolecular bioscience.
[120] Sung Wan Kim,et al. Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer Depot in ZDF Rats , 2003, Pharmaceutical Research.
[121] W. Hennink,et al. Copolymers of 2-(dimethylamino)ethyl methacrylate with ethoxytriethylene glycol methacrylate or N-vinyl-pyrrolidone as gene transfer agents. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[122] S. W. Kim,et al. Water-soluble lipopolymer for gene delivery. , 2001, Bioconjugate chemistry.
[123] R. Wagner. Gene inhibition using antisense oligodeoxynucleotides , 1994, Nature.
[124] M. Hashida,et al. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). , 1997, Biochemical pharmacology.
[125] M. Monsigny,et al. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. , 1993, Nucleic acids research.
[126] Z. Paroo,et al. Biodistribution of phosphodiester and phosphorothioate siRNA. , 2004, Bioorganic & medicinal chemistry letters.
[127] Y. Cheng,et al. Antisense oligonucleotides as therapeutic agents--is the bullet really magical? , 1993, Science.
[128] T. Kissel,et al. Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.
[129] K. Leong,et al. A novel biodegradable gene carrier based on polyphosphoester. , 2001, Journal of the American Chemical Society.
[130] T. Park,et al. A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[131] Mark E. Davis,et al. Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery , 2001 .
[132] S. Groshen,et al. Integrins αvβ3 and αvβ5 Are Expressed by Endothelium of High-Risk Neuroblastoma and Their Inhibition Is Associated with Increased Endogenous Ceramide , 2000 .
[133] J. Mestecky,et al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[134] E Biganzoli,et al. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[135] T. Park,et al. Anti-GAD antibody targeted non-viral gene delivery to islet beta cells. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[136] Y. Lim,et al. Biodegradable polyester, poly[alpha-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. , 2000, Pharmaceutical research.
[137] W. Hennink,et al. Effects of Physicochemical Characteristics of Poly(2-(dimethylamino)ethyl methacrylate)-Based Polyplexes on Cellular Association and Internalization , 2000, Journal of drug targeting.